CPhi Preview 2013: Pfizer
2013 CPhI Exhibitor Preview
Company: Pfizer CentreSource
Description: Pfizer CentreSource (PCS) integrates Pfizer’s world-class analytical, regulatory, technical support and production expertise to provide greater flexibility and help third-party customers work in accelerated timeframes. Key manufacturing assets include world-class bioprocessing facilities in the United States and Europe, as well as high-containment capabilities in Europe. PCS also offers specialty dosage form manufacturing and an array of active pharmaceutical ingredients and fine chemical intermediates.
Website: www.pfizercentresource.com
Booth Number: 30D54
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
